Usana Health Sciences (USNA) Gains from Investment Securities (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Gains from Investment Securities data on file, last reported at $214000.0 in Q2 2026.

• Gains from Investment Securities for Q2 2026 came in at $214000.0, down 90.12% year-over-year; the trailing twelve-month figure through Apr 2026 was $394000.0 (down 83.24% YoY), and the FY2026 annual result was $2.3 million, down 27.18% from the prior year.
• Gains from Investment Securities declined to $214000.0 in Q2 2026 per USNA's latest filing, from $2.5 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $4.2 million in Q2 2022 and troughed at -$4.7 million in Q4 2022.
• A 5-year average of $732647.1 and a median of $214000.0 in 2026 frame the typical range for Gains from Investment Securities.
• On a YoY basis, Gains from Investment Securities climbed as much as 9059.57% in 2022 and fell as far as 226.26% in 2022.
• A 5-year view of Gains from Investment Securities shows it stood at -$4.7 million in 2022, then surged by 102.85% to $134000.0 in 2023, then slumped by 44.78% to $74000.0 in 2024, then slumped by 228.38% to -$95000.0 in 2025, then surged by 325.26% to $214000.0 in 2026.
• Business Quant data shows USNA's Gains from Investment Securities at $214000.0 in Q2 2026, $2.5 million in Q1 2026, and -$95000.0 in Q3 2025.